Skip to main content
OpenTrials
Completed

NCT Number: NCT07689890

Burn Mortality Prediction Scores

This retrospective observational cohort study evaluates hospitalized burn admissions treated at the Burn Center of Gaziantep City Hospital between October 2023 and February 2026. The study aims to compare the ability of three burn severity scoring systems, the Abbreviated Burn Severity Index (ABSI), Revised Baux score, and modified Ryan score, to predict in-hospital mortality.

Electronic medical records were reviewed for demographic characteristics, burn-related variables, inhalation injury, burn depth, intensive care admission, mechanical ventilation, sepsis, surgical procedures, length of hospital stay, and survival status at hospital discharge. The primary outcome is in-hospital mortality. The predictive performance of the scoring systems will be evaluated using receiver operating characteristic analysis and logistic regression.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Gaziantep City Hospital Burn Center

Gaziantep, 27470, Turkey (Türkiye)

About this study

Burn injuries are associated with substantial morbidity, mortality, intensive care use, prolonged hospitalization, and surgical burden. Early identification of patients at high risk of death may support clinical triage, intensive care planning, resource allocation, and communication with patients' families.

This study is a single-center, retrospective, observational cohort study conducted at the Burn Center of Gaziantep City Hospital, a tertiary referral burn center serving southern Türkiye and cross-border regions. The study includes hospitalized burn admissions treated between October 2023 and February 2026.

A total of 1315 burn admission records were screened. Admissions transferred to another facility before final clinical outcome assessment and admissions in which treatment was refused were excluded. After applying eligibility criteria, 1082 hospitalized burn admissions were included in the primary analysis cohort.

The study evaluates the prognostic performance of the Abbreviated Burn Severity Index (ABSI), Revised Baux score, and modified Ryan score for predicting in-hospital mortality. ABSI is calculated using age, sex, total body surface area burned, inhalation injury, and full-thickness burn status. Revised Baux score is calculated using age, total body surface area burned, and the presence of inhalation injury. The modified Ryan score is calculated using age category, total body surface area burned category, inhalation injury, and third-degree burn status.

The primary outcome is in-hospital mortality, defined as death occurring during the index hospitalization. Secondary evaluations include associations between mortality and selected clinical variables, including inhalation injury, sepsis, intensive care admission, mechanical ventilation, number of surgical procedures, and length of hospital stay.

The discriminative performance of prognostic scores will be assessed using receiver operating characteristic analysis. Area under the curve, confidence intervals, optimal cut-off values, sensitivity, and specificity will be reported. Associations between score increments and mortality will be examined using univariable logistic regression.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hospitalized burn admissions treated at the Burn Center of Gaziantep City Hospital between October 2023 and February 2026.

Admissions with a documented in-hospital outcome of discharge alive or death. Admissions with available electronic medical records for age, sex, total body surface area burned, burn depth, inhalation injury, and core clinical variables.

Exclusion criteria

Admissions transferred to another facility before final clinical outcome assessment.

Admissions in which treatment was refused. Admissions without sufficient electronic medical record data for calculation of the prognostic scores or assessment of the primary outcome.

Treatment and study plan

Retrospective Prognostic Score Assessment

Other

ABSI, Revised Baux score, and modified Ryan score were retrospectively calculated using routinely collected electronic medical record data from hospitalized burn admissions. These scores were evaluated for their ability to predict in-hospital mortality. No drug, device, procedure, or treatment intervention was assigned by the study protocol.

Other names: ABSI, Revised Baux score, Modified Ryan score

Primary outcomes

  1. In-Hospital Mortality

    Time frame: From hospital admission to hospital discharge or in-hospital death, assessed up to 240 days.

    In-hospital mortality was defined as death occurring during the index hospitalization for burn injury. Mortality status was determined from electronic hospital records and was used as the primary outcome for evaluating the prognostic performance of burn severity scoring systems.

Secondary outcomes

  1. Area Under the Receiver Operating Characteristic Curve for the Abbreviated Burn Severity Index

    Time frame: Score variables were obtained from admission and early hospitalization records; in-hospital mortality was assessed from hospital admission to discharge or in-hospital death, up to 240 days.

    The Abbreviated Burn Severity Index was calculated using age, sex, total body surface area burned, inhalation injury, and full-thickness burn status recorded in electronic hospital records. Higher scores indicate greater burn severity and higher predicted mortality risk. Predictive discrimination for in-hospital mortality was evaluated using the area under the receiver operating characteristic curve. The area under the curve ranges from 0.0 to 1.0, with higher values indicating better discriminative performance.

  2. Area Under the Receiver Operating Characteristic Curve for the Revised Baux Score

    Time frame: Score variables were obtained from admission and early hospitalization records; in-hospital mortality was assessed from hospital admission to discharge or in-hospital death, up to 240 days.

    The Revised Baux score was calculated using age, total body surface area burned, and the presence of inhalation injury. Higher scores indicate greater burn severity and higher predicted mortality risk. Predictive discrimination for in-hospital mortality was evaluated using the area under the receiver operating characteristic curve. The area under the curve ranges from 0.0 to 1.0, with higher values indicating better discriminative performance.

  3. Predictive Performance of the Modified Ryan Score

    Time frame: Score variables were obtained from admission and early hospitalization records; in-hospital mortality was assessed from hospital admission to discharge or in-hospital death, up to 240 days.

    The predictive performance of the modified Ryan score for in-hospital mortality was evaluated using receiver operating characteristic analysis. Area under the curve, 95% confidence interval, optimal cut-off value, sensitivity, and specificity were calculated.

  4. Association of Selected Clinical Factors With In-Hospital Mortality

    Time frame: Clinical factors and mortality status were assessed from hospital admission to hospital discharge or in-hospital death, up to 240 days.

    The association of selected clinical factors, including inhalation injury, sepsis, intensive care admission, mechanical ventilation, number of surgical procedures, and length of hospital stay, with in-hospital mortality was evaluated using appropriate statistical analyses.

Sponsors and collaborators

Lead sponsor

Gaziantep City Hospital

Other

Registry information

Official study title

Comparative Performance of ABSI, Revised Baux Score, and Modified Ryan Score for In-Hospital Mortality Prediction in Hospitalized Burn Admissions: A Retrospective Cohort Study

Acronym: BURN-PRED

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jul 8, 2026
Registry last updated
Jul 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.